Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accused, ACTR, advocacy, Affimed, alloSCT, altogether, Appeal, art, attack, azacitidine, Baker, Bipartisan, book, branded, bribery, carboplatin, cellular, choose, chromosome, clear, clearance, concurrently, CR, CRi, curb, cytoreduction, decide, decitabine, denintuzumab, dismal, dismissed, disproportionate, District, edema, embolism, encompassing, enfortumab, etoposide, facilitate, feasible, foregoing, formulation, fragile, frail, frame, freely, grew, HL, ifosfamide, immigration, immunological, inadequacy, indefinitely, inhibitor, injection, insignificant, instability, interact, IPR, Italy, Karyopharm, Kingdom, licensee, light, living, LP, mafodotin, MEI, merit, modest, molecule, myelodysplastic, owner, passage, pembroluzimab, perception, pharmacodynamic, Philadelphia, pre, prevailing, properly, PTAB, purport, Radiological, RCHP, repatriated, resale, RICE, scrutinize, settle, talirine, timeline, trastuzumab, treble, unavailability, undergo, unremitted, unrest, Unum, upcoming, USPTO, vadastuximab, valuable, venetoclax
Removed:
advisor, affinity, alternating, Anatomy, characterize, commenced, Condensed, consumed, convened, defucosylation, demonstrating, direct, durable, exclusively, Genome, IDEC, lowered, mid, myeloma, NDA, OBT, Oncovin, Oxford, pediatric, placebo, pool, prevalence, propriety, refuse, represented, sBLA, screened, UK, unconjugated, week, Wyeth
Filing tables
Filing exhibits
Related press release
SGEN similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of Seattle Genetics, Inc.
• | SeaGen Canada Inc. |
• | Seattle Genetics UK, Limited |
• | SeaGen International GmbH |
• | SeaGen International Holdings, Inc. |
• | SeaGen US Holdings, Inc. |
• | SeaGen, Inc. |